Showing results (11-20 of 415) with videos related to
Sort By:
Pageof 42
Seminars in Thrombosis and Hemostasis|April 16, 2004
Low-molecular-weight heparin in thrombosis and cancerShaker A MousaCurrent Pharmaceutical Design|October 8, 2003
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyondShaker A MousaCurrent Opinion in Chemical Biology|July 23, 2002
Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implicationsShaker A MousaClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 14, 2012
Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationshipShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Heparin and low-molecular weight heparins in thrombosis and beyondShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Novel anticoagulant therapy: principle and practiceShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Oral direct factor Xa inhibitors, with special emphasis on rivaroxabanShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Antiplatelet therapies: drug interactions in the management of vascular disordersShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Adhesion molecules: potential therapeutic and diagnostic implicationsShaker A MousaFuture Oncology (London, England)|March 25, 2006
Anti-thrombotics in thrombosis and cancerShaker A MousaPageof 42